Newsfeeds - Spark Newswire

1 minute read

Cyclerion Therapeutics To Share CY6463 MELAS Topline Study Results, Chop To Present CY6463 Preclinical Data At UMDF Mitochondrial Medicine 2022 Symposium

Today, 9:37 PM

Topline results to be shared during the clinical trial update platform session CHOP preclinical data demonstrates CY6463-induced functional improvement in zebrafish disease models

CYCN

2 minute read

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

Today, 9:37 PM

AEMD

57 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 9:37 PM

On Friday, 1043 companies hit new 52-week lows.

AAOI

10 minute read

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 9:37 PM

On Wednesday, 160 companies hit new 52-week lows.

ACLX

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

Today, 9:37 PM

Gainers

ACHL

3 minute read

News

Cyclerion Announces CY6463 Clinical Pipeline And Corporate Updates

By Benzinga Newsdesk

Today, 9:37 PM

Cyclerion Therapeutics, Inc. (NASDAQ:CYCN), a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive function, announced today clinical development updates for CY6463, its lead

CYCN

2 minute read

Movers

12 Health Care Stocks Moving In Thursday’s After-Market Session

By Benzinga Insights

Today, 9:37 PM

Gainers XTL Biopharmaceuticals (NASDAQ:XTLB) shares rose 17.74% to $3.65 during Thursday's after-market session. The market value of their outstanding shares is at $19.2 million.

ASMB